Compare Regeneron Pharmaceuticals Inc (REGN) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs Riot Platforms Inc — how do they compare? Regeneron Pharmaceuticals Inc trades at $653.5 (market cap $70.79B), while Riot Platforms Inc trades at $23.28 (market cap $8.12B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 8.7× Riot Platforms Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Riot Platforms Inc pays none. Which is the better fit depends on your goals.
| REGN | RIOT | |
|---|---|---|
Market Cap | $70.79B | $8.12B |
Sector | Health | Technology |
52-Week High | $812.27 | $28.67 |
52-Week Low | $545.46 | $11.03 |
Enterprise Value | $64.74B | $8.79B |
Dividend Yield | 0.56% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RIOT trades at $19.90, up 8.98% in the past 24 hours, but faces a bearish technical signal despite strong analyst support. The company reported a significant net loss of $663.18 million in 2025 with negative profit margins, though revenue reached $647.44 million. Recent news highlights volatility and strategic partnerships in data center development.
Wall Street remains overwhelmingly bullish with 94% buy ratings and a $28.67 price target, but fundamental weaknesses and cash flow challenges present substantial risks. The stock's outlook depends on improving profitability and successful execution of its business expansion amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
